Your browser doesn't support javascript.
loading
Finite immune imprinting on neutralizing antibody responses to Omicron subvariants by repeated vaccinations.
Song, Xue-Dong; Yang, Guo-Jian; Shi, Chao; Jiang, Xiao-Lin; Wang, Xue-Jun; Zhang, Yu-Wei; Wu, Jie; Zhao, Lian-Xiang; Wang, Ming-Ming; Chen, Rui-Rui; He, Xue-Juan; Dai, Er-Hei; Shen, Yuan; Gao, Hui-Xia; Dong, Gang; Ma, Mai-Juan.
Affiliation
  • Song XD; State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China; Department of Laboratory Medicine, Handan Central Hospital, Hebei Medical University, Handan, China; Hebei Key Laboratory of Immune Mechanism of Major Infectious Diseases and New Technology of Dia
  • Yang GJ; Department of Microbiological Laboratory Technology, School of Public Health, Cheeloo College of Medicine, Shandong University, Key Laboratory of Prevention and Control of Emerging Infectious Diseases and Biosafety in Universities of Shandong, Jinan, China.
  • Shi C; Department of Infectious Disease Control and Prevention, Wuxi Center for Disease Control and Prevention, Wuxi, China.
  • Jiang XL; Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention, Shandong Provincial Center for Disease Control and Prevention, Jinan, China.
  • Wang XJ; State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China.
  • Zhang YW; Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention, Shandong Provincial Center for Disease Control and Prevention, Jinan, China.
  • Wu J; Department of Infectious Disease Control and Prevention, Binzhou Center for Disease Control and Prevention, Binzhou, China.
  • Zhao LX; School of Public Health, Binzhou Medical University, Binzhou, China.
  • Wang MM; State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China.
  • Chen RR; State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China; Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou, China.
  • He XJ; State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China; Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou, China.
  • Dai EH; Hebei Key Laboratory of Immune Mechanism of Major Infectious Diseases and New Technology of Diagnosis and Treatment, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, China.
  • Shen Y; Department of Infectious Disease Control and Prevention, Wuxi Center for Disease Control and Prevention, Wuxi, China.
  • Gao HX; Hebei Key Laboratory of Immune Mechanism of Major Infectious Diseases and New Technology of Diagnosis and Treatment, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, China.
  • Dong G; State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China.
  • Ma MJ; State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China; Department of Microbiological Laboratory Technology, School of Public Health, Cheeloo College of Medicine, Shandong University, Key Laboratory of Prevention and Control of Emerging Infectious Dise
Int J Infect Dis ; 147: 107198, 2024 Aug 06.
Article in En | MEDLINE | ID: mdl-39117174
ABSTRACT

OBJECTIVE:

To investigate the effects of repeated vaccination with ancestral SARS-CoV-2 (Wuhan-hu-1)-based inactivated, recombinant protein subunit or vector-based vaccines on the neutralizing antibody response to Omicron subvariants.

METHODS:

Individuals who received four-dose vaccinations with the Wuhan-hu-1 strain, individuals who were infected with the BA.5 variant alone without prior vaccination, and individuals who experienced a BA.5 breakthrough infection (BTI) following receiving 2-4 doses of the Wuhan-hu-1 vaccine were enrolled. Neutralizing antibodies against D614G, BA.5, XBB.1.5, EG.5.1, and BA.2.86 were detected using a pseudovirus-based neutralization assay. Antigenic cartography was used to analyze cross-reactivity patterns among D614G, BA.5, XBB.1.5, EG.5.1, and BA.2.86 and sera from individuals.

RESULTS:

The highest neutralizing antibody titers against D614G were observed in individuals who only received four-dose vaccination and those who experienced BA.5 BTI, which was also significantly higher than the antibody titers against XBB.1.5, EG.5.1, and BA.2.86. In contrast, only BA.5 infection elicited comparable neutralizing antibody titers against the tested variants. While neutralizing antibody titers against D614G or BA.5 were similar across the cohorts, the neutralizing capacity of antibodies against XBB.1.5, EG.5.1, and BA.2.86 was significantly reduced. BA.5 BTI following heterologous booster induced significantly higher neutralizing antibody titers against the variants, particularly against XBB.1.5 and EG.5.1, than uninfected vaccinated individuals, only BA.5 infected individuals, or those with BA.5 BTI after primary vaccination.

CONCLUSIONS:

Our findings suggest that repeated vaccination with the Wuhan-hu-1 strain imprinted a neutralizing antibody response toward the Wuhan-hu-1 strain with limited effects on the antibody response to the Omicron subvariants.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Int J Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Document type: Article Country of publication: Canada

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Int J Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Document type: Article Country of publication: Canada